Leprosy. An update: Definition, pathogenesis, classification, diagnosis, and treatment;Lepra: puesta al día. Definición, patogénesis, clasificación, diagnóstico y tratamiento

Actas Dermo-Sifiliograficas

Volumn 104, Issue 7, 2013, Pages 554-563

  Eichelmann, K ^a   Gonzalez Gonzalez S E ^a   Salas Alanis, J C ^a   Ocampo Candiani, J ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

Disability; Hansen disease; Leprosy; Multibacillary; Multidrug therapy; Mycobacteria leprae; Paucibacillary; Smear test

Indexed keywords

CLOFAZIMINE; DAPSONE; RIFAMPICIN;

DISEASE CLASSIFICATION; ERYTHEMA; HUMAN; HYPOPIGMENTATION; LEPROSY; PATHOGENESIS; PERIPHERAL NERVE; REVIEW; SENSORY DYSFUNCTION; SKIN BIOPSY; SMEAR;

BACILOSCOPIA; DISABILITY; DISCAPACIDAD; ENFERMEDAD DE HANSEN; HANSEN DISEASE; LEPRA; LEPROSY; M. LEPRAE; MULTIBACILAR; MULTIBACILLARY; MULTIDRUG THERAPY; MULTITERAPIA; MYCOBACTERIA LEPRAE; PAUCIBACILAR; PAUCIBACILLARY; SMEAR TEST;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BCG VACCINE; DRUG THERAPY, COMBINATION; GLYCOLIPIDS; HUMANS; INTRADERMAL TESTS; LEPROMIN; LEPROSTATIC AGENTS; LEPROSY; MYCOBACTERIUM LEPRAE; SEROLOGIC TESTS; SKIN; SPECIES SPECIFICITY; WORLD HEALTH;

EID: 84883292553     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2012.03.003     Document Type: Short Survey

References (43)

1. J. Fitness, K. Tosh, and A. Hill Genetics of suceptibility to leprosy Genes Inmmun 3 2002 441 453
2. W.J. Britton, and D.N. Lockwood Leprosy The Lancet 363 2004 1209 1219
3. X.Y. Han, K.C. Sizer, E.J. Thompson, J. Kabanja, J. Li, and P. Hu Comparative sequence analysis of Mycobacterium leprae and the new leprosy-causing Mycobacterium lepromatosis J Bacteriol 191 2009 6067 6074
4. Global leprosy situation Weekly epidemiological record 2010 World Health Organization Switzerland p. 337-48
5. M. Contreras-Steyls, N. López-Navarro, E. Herrera-Acosta, R. Castillo, G. Ruiz del Portal, and R.J. Busch Lepra importada y su diicultad en el medio actual: a propósito de 7 casos Actas Dermosifiliogr 102 2011 106 113
6. Gulia A, Fried I, Massone C. New insights in the pathogenesis and genetics of leprosy. F1000 Medicine Reports. 2010;27:2
7. Y. Shimoji, V. Ng, K. Matsumura, V. Fischetti, and A. Rambukkana A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion Proc Natl Acad Sci U S A 96 1999 9857 9862
8. A. Alter, A. Grant, L. Abel, A. Alcaïs, and E. Schurr Leprosy as a genetic disease Mamm Genome 22 2011 19 31
9. M. Balagon, R. Gelber, R. Abalos, and R. Cellona Reactions following completion of 1 and 2 year multidrug therapy (MDT) Am J Trop Med Hyg 83 2010 637 644
10. M. Bakker, M. Hatta, and A. Kwenang Population survey to determine risk factors for Mycobacterium leprae transmission and infection Int J Epidemiol 33 2004 1329 1336
11. T.F. Davey, and R.J. Rees The nasal discharge in leprosy: clinical and bacteriological aspects Lepr Rev 25 1974 121 134
12. A. Ghorpade Ornamental tattoos and skin lesions. Tattoo inoculation borderline tuberculoid leprosy Int J Dermatol 48 2009 11 13
13. M.E. Duncan, R. Melsom, J.M. Pearson, S. Menzel, and R.S. Barnetson A clinical and immunological study of four babies of mothers with lepromatous leprosy, two of whom developed leprosy in infancy Int J Lepr Other Mycobact Dis 51 1983 7 17
14. D. Ridley, and W. Jopling Classification of leprosy according to immunity. A five-group system Int J Lepr Other Mycobact Dis 34 1966 255 273
15. S.L. Moschella An update on the diagnosis and treatment of leprosy J Am Acad Dermatol 51 2004 417 426
16. L. Vera-Cabrera, W.G. Escalante-Fuentes, M. Gomez-Flores, J. Ocampo-Candiani, P. Busso, and P. Singh Case of Diffuse Lepromatous Leprosy Associated with Mycobacterium lepromatosis J Clin Microbiol 49 2011 4366 4368
17. L. Rodríguez-Pazos, S. Gómez-Bernal, D. Sánchez-Aguilar, and J. Toribio Leprorreacción tipo 1 y embarazo Actas Dermosifiliogr 101 2010 190 191
18. R. Garg, and M. Dehran Leprosy: a precipitating factor for complex regional pain syndrome Minerva Anestesiol 76 2010 758 760
19. V. Sehgal, K. Sardana, and S. Dogra Management of complications following leprosy: an evolving scenario J Dermatolog Treat 18 2007 366 374
20. D.D. Maki, D.M. Yousem, C. Corcoran, and S.L. Galetta MR imaging of Dejerine-Sottas disease AJNR Am J Neuroradiol 20 1999 378 380
21. G.H. Faget, and A. Mayoral Bone changes in leprosy, a clinical and roentgenological study of 505 cases Radiology 42 1944 1 13
22. B.D. Chhabriya, N.C. Sharma, N.K. Bansal, and G.R. Agrawal Bone changes in leprosy. A study of 50 cases Indian J Lepr 57 1985 632 639
23. Z. Martínez de Lagrán, A. Arrieta-Egurrola, R. González-Pérez, and R. Soloeta-Arechavala Complicaciones óseas en un paciente con lepra lepromatosa Actas Dermosifiliogr 100 2009 615 617
24. F. Vargas-Ocampo Diffuse leprosy of Lucio and Latapí: a histologic study Lepr Rev 78 2007 248 260
25. M. Hatta, S. van Beers, B. Madjid, A. Djumadi, M. de Wit, and P. Klatser Distribution and persistence of Mycobacterium leprae nasal carriage among a population in which leprosy is endemic in Indonesia Trans R Soc Trop Med Hyg 89 1995 381 385
26. A. Aggarwal, and A. Pandey Inverse sampling to study disease burden of leprosy Indian J Med Res 132 2010 438 441
27. P. Ramaprasad, A. Fernando, S. Madhale, J.R. Rao, V.K. Edward, and P.D. Samson Transmission and protection in leprosy: indications of the role of mucosal immunity Lepr Rev 68 1997 301 315
28. E. Silva, A. Iyer, S. Ura, J.R. Lauris, B. Naafs, and P.K. Das Utility of measuring serum levels of anti-PGL-I antibody, neopterin and C-reactive protein in monitoring leprosy patients during multi-drug treatment and reactions Trop Med Int Health 12 2007 1450 1458
29. S. Banerjee, K. Sarkar, S. Gupta, P.S. Mahapatra, S. Gupta, and S. Guha Multiplex PCR technique could be an alternative approach for early detection of leprosy among close contacts - a pilot study from India BMC Infect Dis 10 2010 252
30. A.C. da Costa Martins, A. Miranda, M.L. Wan-del-Rey de Oliviera, S. Bührer Sékula, and A. Martinez Nasal mucosa study of leprosy contacts with positive serology for the phenolic glycolipid 1 antigen Braz J Otorhinolaryngol 76 2010 579 587
31. J. Terencio de las Aguas Estado Actual de la Terapéutica de la Lepra DCMQ 6 2008 118 125
32. J. Terencio de las Aguas Contagiosidad de la lepra, por Juan de Azúa Actas Dermosifiliogr 100 2009 756 758
33. J. Vieira, J. Riveira, A.N. Martins, J. da Silva, and C. Salgado Methemoglobinemia and dapsone levels in patients with leprosy Braz J Infect Dis 14 2010 319 321
34. M. Kai, M. Matsuoka, N. Nakata, S. Maeda, M. Gidoh, and Y. Maeda Diaminodiphenylsulfone resistance of Mycobacterium leprae due to mutations in the dihydropteroate synthase gene FEMS Microbiol Lett 177 1999 231 235
35. W.J. Britton The management of leprosy reversal reactions Lepr Rev 69 1998 225 234
36. S.L. Walker, and D.N. Lockwood Leprosy type 1 (reversal) reactions and their management Lepr Rev 79 2008 372 386
37. P. Jakeman, and W.C. Smith Thalidomide in leprosy reaction Lancet 343 1994 432 433
38. V. Heriberto, and A. Roberto Talidomida en dermatología. Revisión de sus orígenes, su actual redescubrimiento y sus nuevas aplicaciones Dermatología Rev Mex 42 1998 252 265
39. J.M. Ramos, F. Reyes, D. Lemma, I. Belinchón, and J.R. Gomez Disability profile in leprosy patients' diagnoses in a rural reference leprosy centre in Ethiopia during 1999-2009 Trop Doct 41 2011 51 53
40. K. Mitsuda, and M. Ogawa A study of one hundred and fifty autopsies on cases of leprosy Int J Lepr Other Mycobact Dis 5 1937 53 60
41. D.R. Azulay Vacinação anti-hansênica An Bras Dermatol 77 2002 489 494
42. J.M. Pönnighaus, P.E. Fine, J.A. Sterne, R.J. Wilson, E. Msosa, and P.J. Gruer Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi Lancet 339 1992 636 639
43. World Health Organization. WHO recommended MDT regimens. 2012 [consultado 04 Feb 2011]. Disponible en: http://www.who.int/lep/mdt/regimens/en/index.html#